Journal
PLOS ONE
Volume 6, Issue 9, Pages -Publisher
PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0023348
Keywords
-
Categories
Funding
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [K01 AR054114]
- National Heart, Lung, and Blood Institute (NHLBI) [SBIR R44 HL092706-01]
- National Cancer Institute (NCI) [R21 CA143787]
- The Ohio State University
Ask authors/readers for more resources
Background: Mechanisms of human V gamma 2V delta 2 T cell-mediated tumor immunity have yet to be fully elucidated. Methods and Findings: At least some tumor cell recognition is mediated by NKG2D-MICA interactions. Herein, by using MTT assay and PI-BrdU co-staining and Western-blot, we show that these V gamma 2V delta 2 T cells can limit the proliferation of ovarian tumor cells by down regulation of apoptosis and cell cycle related molecules in tumor cells. Cell-to-cell contact is critical. gamma delta T cell-resistant, but not susceptible ovarian tumor cells escape gamma delta T cell-mediated immune recognition by up-regulating pErk1/2, thereby decreasing surface MICA levels. Erk1/2 inhibitor pretreatment or incubation prevents this MICA decrease, while up-regulating key cell cycle related molecules such as CDK2, CDK4 and Cyclin D1, as well as apoptosis related molecules making resistant tumor cells now vulnerable to gamma delta T cell-mediated lysis. Conclusion: These findings demonstrate novel effects of gamma delta T cells on ovarian tumor cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available